Tmp Nominee Ii, Llc - Net Worth and Insider Trading

Tmp Nominee Ii, Llc Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Tmp Nominee Ii, Llc owns 7 companies in total, including CAS Medical Systems Inc (CASM) , Ocera Therapeutics Inc (OCRX) , and Invitae Corp (NVTAQ) among others .

Click here to see the complete history of Tmp Nominee Ii, Llc’s form 4 insider trades.

Insider Ownership Summary of Tmp Nominee Ii, Llc

Ticker	Comapny	Transaction Date	Type of Owner
CASM	CAS Medical Systems Inc	2019-04-18	10 percent owner
OCRX	Ocera Therapeutics Inc	2017-01-30	10 percent owner
NVTAQ	Invitae Corp	2016-12-01	10 percent owner
		2013-01-14	10 percent owner
		2010-11-29	other: See Footnote (10)
		2021-09-10	10 percent owner
		2021-09-10	10 percent owner

Tmp Nominee Ii, Llc Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Tmp Nominee Ii, Llc Ownership Network

Ownership Network List of Tmp Nominee Ii, Llc

No Data

Ownership Network Relation of Tmp Nominee Ii, Llc

Tmp Nominee Ii, Llc Owned Company Details

What does CAS Medical Systems Inc do?

Who are the key executives at CAS Medical Systems Inc?

Tmp Nominee Ii, Llc is the 10 percent owner of CAS Medical Systems Inc. Other key executives at CAS Medical Systems Inc include director & President and CEO Thomas M Patton , director & 10 percent owner James E Thomas , and 10 percent owner Thomas, Mcnerney & Partners Ii L.p. .

CAS Medical Systems Inc (CASM) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of CAS Medical Systems Inc (CASM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of CAS Medical Systems Inc (CASM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

CAS Medical Systems Inc (CASM)'s detailed insider trading history can be found in Insider Trading Tracker table.

CAS Medical Systems Inc Insider Transactions

No Available Data

What does Ocera Therapeutics Inc do?

Who are the key executives at Ocera Therapeutics Inc?

Tmp Nominee Ii, Llc is the 10 percent owner of Ocera Therapeutics Inc. Other key executives at Ocera Therapeutics Inc include 10 percent owner Brian H Dovey , 10 percent owner Domain Partners Viii, L.p. , and 10 percent owner Dp Viii Associates, L.p. .

Ocera Therapeutics Inc (OCRX) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Ocera Therapeutics Inc (OCRX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Ocera Therapeutics Inc (OCRX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Ocera Therapeutics Inc (OCRX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Ocera Therapeutics Inc Insider Transactions

No Available Data

What does Invitae Corp do?

Who are the key executives at Invitae Corp?

Tmp Nominee Ii, Llc is the 10 percent owner of Invitae Corp. Other key executives at Invitae Corp include Chief Financial Officer Ana J. Schrank , Chief Commercial Officer Robert M. Guigley , and See Remarks Robert Iv Dickey .

Invitae Corp (NVTAQ) Insider Trades Summary

Over the past 18 months, Tmp Nominee Ii, Llc made no insider transaction in Invitae Corp (NVTAQ). Other recent insider transactions involving Invitae Corp (NVTAQ) include a net sale of 92,717 shares made by Kenneth D. Knight , a net sale of 89,529 shares made by Yafei Wen , and a net sale of 36,187 shares made by Robert L Nussbaum .

In summary, during the past 3 months, insiders sold 0 shares of Invitae Corp (NVTAQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 332,151 shares of Invitae Corp (NVTAQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 332,151 shares.

Invitae Corp (NVTAQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

Invitae Corp Insider Transactions

No Available Data

What does Celator Pharmaceuticals Inc do?

Who are the key executives at Celator Pharmaceuticals Inc?

Tmp Nominee Ii, Llc is the 10 percent owner of Celator Pharmaceuticals Inc. Other key executives at Celator Pharmaceuticals Inc include other: Member of a 10% Group Eric W Roberts , other: See Remarks Section Cdk Associates, L.l.c. , and other: See Remarks Section Caxton Corp .

Celator Pharmaceuticals Inc (CPXX) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Celator Pharmaceuticals Inc (CPXX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Celator Pharmaceuticals Inc (CPXX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Celator Pharmaceuticals Inc (CPXX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Celator Pharmaceuticals Inc Insider Transactions

No Available Data

What does Zogenix Inc do?

Who are the key executives at Zogenix Inc?

Tmp Nominee Ii, Llc is the other: See Footnote (10) of Zogenix Inc. Other key executives at Zogenix Inc include EVP & CHIEF COMMERCIAL OFFICER Ashish M Sagrolikar , EVP/Chief Development Officer Gail M Farfel , and director & President and CEO Stephen J Farr .

Zogenix Inc (ZGNX) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Zogenix Inc (ZGNX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Zogenix Inc (ZGNX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Zogenix Inc (ZGNX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Zogenix Inc Insider Transactions

No Available Data

What does Clarus Therapeutics Holdings Inc do?

Who are the key executives at Clarus Therapeutics Holdings Inc?

Tmp Nominee Ii, Llc is the 10 percent owner of Clarus Therapeutics Holdings Inc. Other key executives at Clarus Therapeutics Holdings Inc include 10 percent owner Thomas Mcnerney & Partners Lp , director & Chief Executive Officer Robert E. Dudley , and Chief Financial Officer Richard D Peterson .

Clarus Therapeutics Holdings Inc (CRXTQ) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Clarus Therapeutics Holdings Inc (CRXTQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Clarus Therapeutics Holdings Inc (CRXTQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Clarus Therapeutics Holdings Inc (CRXTQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

Clarus Therapeutics Holdings Inc Insider Transactions

No Available Data

What does Blue Water Acquisition Corp do?

Who are the key executives at Blue Water Acquisition Corp?

Tmp Nominee Ii, Llc is the 10 percent owner of Blue Water Acquisition Corp. Other key executives at Blue Water Acquisition Corp include director & Chief Executive Officer Robert E. Dudley , Chief Financial Officer Richard D Peterson , and Chief Commercial Officer Frank Jaeger .

Blue Water Acquisition Corp (BLUWU) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Blue Water Acquisition Corp (BLUWU) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Blue Water Acquisition Corp (BLUWU) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Blue Water Acquisition Corp (BLUWU)'s detailed insider trading history can be found in Insider Trading Tracker table.

Blue Water Acquisition Corp Insider Transactions

No Available Data

Tmp Nominee Ii, Llc Mailing Address

Above is the net worth, insider trading, and ownership report for Tmp Nominee Ii, Llc. You might contact Tmp Nominee Ii, Llc via mailing address: 45 South Seventh Street, Suite 3060, Minneapolis Mn 55402.

Discussions on Tmp Nominee Ii, Llc

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us ETF Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.